TG 59:6 (BioDeep_00000631749)

   

LipidSearch


代谢物信息卡片


1-(9Z,12Z-heptadecadienoyl)-2-(11Z,14Z-eicosadienoyl)-3-(13Z,16Z-docosadienoyl)-sn-glycerol

化学式: C62H108O6 (948.8145468)
中文名称:
谱图信息: 最多检出来源 Homo sapiens(lipidomics) 100%

分子结构信息

SMILES: C(OC(=O)CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CC)[C@]([H])(OC(CCCCCCCCCCCCCCCCCC)=O)COC(CCCCCCCCCCCCCCCCC)=O
InChI: InChI=1S/C62H108O6/c1-4-7-10-13-16-19-22-25-28-30-31-33-34-37-40-43-46-49-52-55-61(64)67-58-59(57-66-60(63)54-51-48-45-42-39-36-27-24-21-18-15-12-9-6-3)68-62(65)56-53-50-47-44-41-38-35-32-29-26-23-20-17-14-11-8-5-2/h15-20,24-29,59H,4-14,21-23,30-58H2,1-3H3/b18-15-,19-16-,20-17-,27-24-,28-25-,29-26-/t59-/m1/s1

描述信息

同义名列表

181 个代谢物同义名

1-9Z-nonadecenoyl-2-(11Z,14Z-eicosadienoyl)-3-(8Z,11Z,14Z-eicosatrienoyl)-sn-glycerol; TG(19:1(9Z)/20:2(11Z,14Z)/20:3(8Z,11Z,14Z))[iso6]; TG(19:1_20:2_20:3); TG(59:6); TG 59:6; 1-9Z-nonadecenoyl-2-(11Z-eicosenoyl)-3-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-sn-glycerol; TG(19:1(9Z)/20:1(11Z)/20:4(5Z,8Z,11Z,14Z))[iso6]; TG(19:1_20:1_20:4); 1-9Z-nonadecenoyl-2-eicosanoyl-3-(5Z,8Z,11Z,14Z,17Z-eicosapentaenoyl)-sn-glycerol; TG(19:1(9Z)/20:0/20:5(5Z,8Z,11Z,14Z,17Z))[iso6]; TG(19:1_20:0_20:5); 1-(6Z,9Z,12Z,15Z-octadecatetraenoyl)-2-(11Z,14Z-eicosadienoyl)-3-heneicosanoyl-sn-glycerol; TG(18:4(6Z,9Z,12Z,15Z)/20:2(11Z,14Z)/21:0)[iso6]; TG(18:4_20:2_21:0); 1-(6Z,9Z,12Z,15Z-octadecatetraenoyl)-2-9Z-nonadecenoyl-3-11Z-docosenoyl-sn-glycerol; TG(18:4(6Z,9Z,12Z,15Z)/19:1(9Z)/22:1(11Z))[iso6]; TG(18:4_19:1_22:1); 1-(6Z,9Z,12Z,15Z-octadecatetraenoyl)-2-nonadecanoyl-3-(13Z,16Z-docosadienoyl)-sn-glycerol; TG(18:4(6Z,9Z,12Z,15Z)/19:0/22:2(13Z,16Z))[iso6]; TG(18:4_19:0_22:2); 1-(9Z,12Z,15Z-octadecatrienoyl)-2-9Z-nonadecenoyl-3-(13Z,16Z-docosadienoyl)-sn-glycerol; TG(18:3(9Z,12Z,15Z)/19:1(9Z)/22:2(13Z,16Z))[iso6]; TG(18:3_19:1_22:2); 1-(6Z,9Z,12Z-octadecatrienoyl)-2-(8Z,11Z,14Z-eicosatrienoyl)-3-heneicosanoyl-sn-glycerol; TG(18:3(6Z,9Z,12Z)/20:3(8Z,11Z,14Z)/21:0)[iso6]; TG(18:3_20:3_21:0); 1-(6Z,9Z,12Z-octadecatrienoyl)-2-9Z-nonadecenoyl-3-(13Z,16Z-docosadienoyl)-sn-glycerol; TG(18:3(6Z,9Z,12Z)/19:1(9Z)/22:2(13Z,16Z))[iso6]; 1-(6Z,9Z,12Z-octadecatrienoyl)-2-nonadecanoyl-3-(10Z,13Z,16Z-docosatrienoyl)-sn-glycerol; TG(18:3(6Z,9Z,12Z)/19:0/22:3(10Z,13Z,16Z))[iso6]; TG(18:3_19:0_22:3); 1-(9Z,12Z-octadecadienoyl)-2-9Z-nonadecenoyl-3-(10Z,13Z,16Z-docosatrienoyl)-sn-glycerol; TG(18:2(9Z,12Z)/19:1(9Z)/22:3(10Z,13Z,16Z))[iso6]; TG(18:2_19:1_22:3); 1-(9Z-octadecenoyl)-2-9Z-nonadecenoyl-3-(7Z,10Z,13Z,16Z-docosatetraenoyl)-sn-glycerol; TG(18:1(9Z)/19:1(9Z)/22:4(7Z,10Z,13Z,16Z))[iso6]; TG(18:1_19:1_22:4); 1-octadecanoyl-2-9Z-nonadecenoyl-3-(7Z,10Z,13Z,16Z,19Z-docosapentaenoyl)-sn-glycerol; TG(18:0/19:1(9Z)/22:5(7Z,10Z,13Z,16Z,19Z))[iso6]; TG(18:0_19:1_22:5); 1-(9Z,12Z-heptadecadienoyl)-2-(8Z,11Z,14Z-eicosatrienoyl)-3-11Z-docosenoyl-sn-glycerol; TG(17:2(9Z,12Z)/20:3(8Z,11Z,14Z)/22:1(11Z))[iso6]; TG(17:2_20:3_22:1); 1-(9Z-heptadecenoyl)-2-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-3-11Z-docosenoyl-sn-glycerol; TG(17:1(9Z)/20:4(5Z,8Z,11Z,14Z)/22:1(11Z))[iso6]; TG(17:1_20:4_22:1); 1-heptadecanoyl-2-(5Z,8Z,11Z,14Z,17Z-eicosapentaenoyl)-3-11Z-docosenoyl-sn-glycerol; TG(17:0/20:5(5Z,8Z,11Z,14Z,17Z)/22:1(11Z))[iso6]; TG(17:0_20:5_22:1); 1-(9Z-pentadecenoyl)-2-(13Z,16Z-docosadienoyl)-3-(10Z,13Z,16Z-docosatrienoyl)-sn-glycerol; TG(15:1(9Z)/22:2(13Z,16Z)/22:3(10Z,13Z,16Z))[iso6]; TG(15:1_22:2_22:3); 1-(9Z-pentadecenoyl)-2-11Z-docosenoyl-3-(7Z,10Z,13Z,16Z-docosatetraenoyl)-sn-glycerol; TG(15:1(9Z)/22:1(11Z)/22:4(7Z,10Z,13Z,16Z))[iso6]; TG(15:1_22:1_22:4); 1-(9Z-pentadecenoyl)-2-docosanoyl-3-(7Z,10Z,13Z,16Z,19Z-docosapentaenoyl)-sn-glycerol; TG(15:1(9Z)/22:0/22:5(7Z,10Z,13Z,16Z,19Z))[iso6]; TG(15:1_22:0_22:5); 1-pentadecanoyl-2-(13Z,16Z-docosadienoyl)-3-(7Z,10Z,13Z,16Z-docosatetraenoyl)-sn-glycerol; TG(15:0/22:2(13Z,16Z)/22:4(7Z,10Z,13Z,16Z))[iso6]; TG(15:0_22:2_22:4); 1-pentadecanoyl-2-11Z-docosenoyl-3-(7Z,10Z,13Z,16Z,19Z-docosapentaenoyl)-sn-glycerol; TG(15:0/22:1(11Z)/22:5(7Z,10Z,13Z,16Z,19Z))[iso6]; TG(15:0_22:1_22:5); 1-pentadecanoyl-2-docosanoyl-3-(4Z,7Z,10Z,13Z,16Z,19Z-docosahexaenoyl)-sn-glycerol; TG(15:0/22:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))[iso6]; TG(15:0_22:0_22:6); 1-pentadecanoyl-2,3-di-(10Z,13Z,16Z-docosatrienoyl)-sn-glycerol; TG(15:0/22:3(10Z,13Z,16Z)/22:3(10Z,13Z,16Z))[iso3]; TG(15:0_22:3_22:3); 1-hexadecanoyl-2-heneicosanoyl-3-(4Z,7Z,10Z,13Z,16Z,19Z-docosahexaenoyl)-sn-glycerol; TG(16:0/21:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))[iso6]; TG(16:0/21:0/22:6)[iso6]; TG(16:0_21:0_22:6); 1-(9Z-hexadecenoyl)-2-heneicosanoyl-3-(7Z,10Z,13Z,16Z,19Z-docosapentaenoyl)-sn-glycerol; TG(16:1(9Z)/21:0/22:5(7Z,10Z,13Z,16Z,19Z))[iso6]; TG(16:1/21:0/22:5)[iso6]; TG(16:1_21:0_22:5); 1-octadecanoyl-2-nonadecanoyl-3-(4Z,7Z,10Z,13Z,16Z,19Z-docosahexaenoyl)-sn-glycerol; TG(18:0/19:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))[iso6]; TG(18:0/19:0/22:6)[iso6]; TG(18:0_19:0_22:6); 1-(9Z-octadecenoyl)-2-nonadecanoyl-3-(7Z,10Z,13Z,16Z,19Z-docosapentaenoyl)-sn-glycerol; TG(18:1(9Z)/19:0/22:5(7Z,10Z,13Z,16Z,19Z))[iso6]; TG(18:1/19:0/22:5)[iso6]; TG(18:1_19:0_22:5); 1-(9Z,12Z-octadecadienoyl)-2-nonadecanoyl-3-(7Z,10Z,13Z,16Z-docosatetraenoyl)-sn-glycerol; TG(18:2(9Z,12Z)/19:0/22:4(7Z,10Z,13Z,16Z))[iso6]; TG(18:2/19:0/22:4)[iso6]; TG(18:2_19:0_22:4); 1-(9Z,12Z,15Z-octadecatrienoyl)-2-(8Z,11Z,14Z-eicosatrienoyl)-3-heneicosanoyl-sn-glycerol; TG(18:3(9Z,12Z,15Z)/20:3(8Z,11Z,14Z)/21:0)[iso6]; TG(18:3/20:3/21:0)[iso6]; 1-(9Z,12Z-octadecadienoyl)-2-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-3-heneicosanoyl-sn-glycerol; TG(18:2(9Z,12Z)/20:4(5Z,8Z,11Z,14Z)/21:0)[iso6]; TG(18:2/20:4/21:0)[iso6]; TG(18:2_20:4_21:0); 1-(9Z-octadecenoyl)-2-(5Z,8Z,11Z,14Z,17Z-eicosapentaenoyl)-3-heneicosanoyl-sn-glycerol; TG(18:1(9Z)/20:5(5Z,8Z,11Z,14Z,17Z)/21:0)[iso6]; TG(18:1/20:5/21:0)[iso6]; TG(18:1_20:5_21:0); 1-(9Z,12Z-heptadecadienoyl)-2-(11Z,14Z-eicosadienoyl)-3-(13Z,16Z-docosadienoyl)-sn-glycerol; TG(17:2(9Z,12Z)/20:2(11Z,14Z)/22:2(13Z,16Z))[iso6]; TG(17:2/20:2/22:2)[iso6]; TG(17:2_20:2_22:2); 1-(9Z-heptadecenoyl)-2-(8Z,11Z,14Z-eicosatrienoyl)-3-(13Z,16Z-docosadienoyl)-sn-glycerol; TG(17:1(9Z)/20:3(8Z,11Z,14Z)/22:2(13Z,16Z))[iso6]; TG(17:1/20:3/22:2)[iso6]; TG(17:1_20:3_22:2); 1-heptadecanoyl-2-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-3-(13Z,16Z-docosadienoyl)-sn-glycerol; TG(17:0/20:4(5Z,8Z,11Z,14Z)/22:2(13Z,16Z))[iso6]; TG(17:0/20:4/22:2)[iso6]; TG(17:0_20:4_22:2); 1-(9Z,12Z,15Z-octadecatrienoyl)-2-nonadecanoyl-3-(10Z,13Z,16Z-docosatrienoyl)-sn-glycerol; TG(18:3(9Z,12Z,15Z)/19:0/22:3(10Z,13Z,16Z))[iso6]; TG(18:3/19:0/22:3)[iso6]; 1-heptadecanoyl-2-eicosanoyl-3-(4Z,7Z,10Z,13Z,16Z,19Z-docosahexaenoyl)-sn-glycerol; TG(17:0/20:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))[iso6]; TG(17:0/20:0/22:6)[iso6]; TG(17:0_20:0_22:6); 1-(9Z-heptadecenoyl)-2-eicosanoyl-3-(7Z,10Z,13Z,16Z,19Z-docosapentaenoyl)-sn-glycerol; TG(17:1(9Z)/20:0/22:5(7Z,10Z,13Z,16Z,19Z))[iso6]; TG(17:1/20:0/22:5)[iso6]; TG(17:1_20:0_22:5); 1-heptadecanoyl-2-(11Z-eicosenoyl)-3-(7Z,10Z,13Z,16Z,19Z-docosapentaenoyl)-sn-glycerol; TG(17:0/20:1(11Z)/22:5(7Z,10Z,13Z,16Z,19Z))[iso6]; TG(17:0/20:1/22:5)[iso6]; TG(17:0_20:1_22:5); 1-(9Z,12Z-heptadecadienoyl)-2-eicosanoyl-3-(7Z,10Z,13Z,16Z-docosatetraenoyl)-sn-glycerol; TG(17:2(9Z,12Z)/20:0/22:4(7Z,10Z,13Z,16Z))[iso6]; TG(17:2/20:0/22:4)[iso6]; TG(17:2_20:0_22:4); 1-(9Z-heptadecenoyl)-2-(11Z-eicosenoyl)-3-(7Z,10Z,13Z,16Z-docosatetraenoyl)-sn-glycerol; TG(17:1(9Z)/20:1(11Z)/22:4(7Z,10Z,13Z,16Z))[iso6]; TG(17:1/20:1/22:4)[iso6]; TG(17:1_20:1_22:4); 1-heptadecanoyl-2-(11Z,14Z-eicosadienoyl)-3-(7Z,10Z,13Z,16Z-docosatetraenoyl)-sn-glycerol; TG(17:0/20:2(11Z,14Z)/22:4(7Z,10Z,13Z,16Z))[iso6]; TG(17:0/20:2/22:4)[iso6]; TG(17:0_20:2_22:4); 1-(9Z,12Z-heptadecadienoyl)-2-(8Z,11Z,14Z-eicosatrienoyl)-3-(13Z-docosenoyl)-sn-glycerol; TG(17:2(9Z,12Z)/20:3(8Z,11Z,14Z)/22:1(13Z))[iso6]; TG(17:2/20:3/22:1)[iso6]; 1-(9Z-heptadecenoyl)-2-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-3-(13Z-docosenoyl)-sn-glycerol; TG(17:1(9Z)/20:4(5Z,8Z,11Z,14Z)/22:1(13Z))[iso6]; TG(17:1/20:4/22:1)[iso6]; 1-heptadecanoyl-2-(5Z,8Z,11Z,14Z,17Z-eicosapentaenoyl)-3-(13Z-docosenoyl)-sn-glycerol; TG(17:0/20:5(5Z,8Z,11Z,14Z,17Z)/22:1(13Z))[iso6]; TG(17:0/20:5/22:1)[iso6]; 1-(9Z,12Z-heptadecadienoyl)-2-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-3-docosanoyl-sn-glycerol; TG(17:2(9Z,12Z)/20:4(5Z,8Z,11Z,14Z)/22:0)[iso6]; TG(17:2/20:4/22:0)[iso6]; TG(17:2_20:4_22:0); 1-(9Z-heptadecenoyl)-2-(5Z,8Z,11Z,14Z,17Z-eicosapentaenoyl)-3-docosanoyl-sn-glycerol; TG(17:1(9Z)/20:5(5Z,8Z,11Z,14Z,17Z)/22:0)[iso6]; TG(17:1/20:5/22:0)[iso6]; TG(17:1_20:5_22:0); 1-nonadecanoyl-2-(11Z-eicosenoyl)-3-(5Z,8Z,11Z,14Z,17Z-eicosapentaenoyl)-sn-glycerol; TG(19:0/20:1(11Z)/20:5(5Z,8Z,11Z,14Z,17Z))[iso6]; TG(19:0/20:1/20:5)[iso6]; TG(19:0_20:1_20:5); 1-nonadecanoyl-2-(11Z,14Z-eicosadienoyl)-3-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-sn-glycerol; TG(19:0/20:2(11Z,14Z)/20:4(5Z,8Z,11Z,14Z))[iso6]; TG(19:0/20:2/20:4)[iso6]; TG(19:0_20:2_20:4); 1-nonadecanoyl-2,3-di-(8Z,11Z,14Z-eicosatrienoyl)-sn-glycerol; TG(19:0/20:3(8Z,11Z,14Z)/20:3(8Z,11Z,14Z))[iso3]; TG(19:0/20:3/20:3)[iso3]; TG(19:0_20:3_20:3); 1-(9Z,12Z-heptadecadienoyl)-2-(11Z-eicosenoyl)-3-(10Z,13Z,16Z-docosatrienoyl)-sn-glycerol; TG(17:2(9Z,12Z)/20:1(11Z)/22:3(10Z,13Z,16Z))[iso6]; TG(17:2/20:1/22:3)[iso6]; TG(17:2_20:1_22:3); 1-(9Z-heptadecenoyl)-2-(11Z,14Z-eicosadienoyl)-3-(10Z,13Z,16Z-docosatrienoyl)-sn-glycerol; TG(17:1(9Z)/20:2(11Z,14Z)/22:3(10Z,13Z,16Z))[iso6]; TG(17:1/20:2/22:3)[iso6]; TG(17:1_20:2_22:3); 1-heptadecanoyl-2-(8Z,11Z,14Z-eicosatrienoyl)-3-(10Z,13Z,16Z-docosatrienoyl)-sn-glycerol; TG(17:0/20:3(8Z,11Z,14Z)/22:3(10Z,13Z,16Z))[iso6]; TG(17:0/20:3/22:3)[iso6]; TG(17:0_20:3_22:3)



数据库引用编号

106 个数据库交叉引用编号

分类词条

相关代谢途径

Reactome(0)

BioCyc(0)

PlantCyc(0)

代谢反应

0 个相关的代谢反应过程信息。

Reactome(0)

BioCyc(0)

WikiPathways(0)

Plant Reactome(0)

INOH(0)

PlantCyc(0)

COVID-19 Disease Map(0)

PathBank(0)

PharmGKB(0)

0 个相关的物种来源信息

在这里通过桑基图来展示出与当前的这个代谢物在我们的BioDeep知识库中具有相关联信息的其他代谢物。在这里进行关联的信息来源主要有:

  • PubMed: 来源于PubMed文献库中的文献信息,我们通过自然语言数据挖掘得到的在同一篇文献中被同时提及的相关代谢物列表,这个列表按照代谢物同时出现的文献数量降序排序,取前10个代谢物作为相关研究中关联性很高的代谢物集合展示在桑基图中。
  • NCBI Taxonomy: 通过文献数据挖掘,得到的代谢物物种来源信息关联。这个关联信息同样按照出现的次数降序排序,取前10个代谢物作为高关联度的代谢物集合展示在桑吉图上。
  • Chemical Taxonomy: 在物质分类上处于同一个分类集合中的其他代谢物
  • Chemical Reaction: 在化学反应过程中,存在为当前代谢物相关联的生化反应过程中的反应底物或者反应产物的关联代谢物信息。

点击图上的相关代谢物的名称,可以跳转到相关代谢物的信息页面。



文献列表

  • L Ovesen, H Boeing. The use of biomarkers in multicentric studies with particular consideration of iodine, sodium, iron, folate and vitamin D. European journal of clinical nutrition. 2002 May; 56 Suppl 2(?):S12-7. doi: 10.1038/sj.ejcn.1601424. [PMID: 12082513]
  • R Sekura, A Meister. Covalent interaction of L-2-amino-4-oxo-5-chloropentanoate at glutamate binding site of gamma-glutamylcysteine synthetase. The Journal of biological chemistry. 1977 Apr; 252(8):2606-10. doi: NULL. [PMID: 15993]